1. Home
  2. LMB vs CTKB Comparison

LMB vs CTKB Comparison

Compare LMB & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Limbach Holdings Inc.

LMB

Limbach Holdings Inc.

HOLD

Current Price

$47.75

Market Cap

579.3M

ML Signal

HOLD

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$5.40

Market Cap

541.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMB
CTKB
Founded
1901
1990
Country
United States
United States
Employees
1400
N/A
Industry
Engineering & Construction
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
579.3M
541.1M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
LMB
CTKB
Price
$47.75
$5.40
Analyst Decision
Buy
Buy
Analyst Count
5
4
Target Price
★ $75.00
$5.56
AVG Volume (30 Days)
200.8K
★ 1.3M
Earning Date
11-03-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 25.68
N/A
EPS
★ 0.76
N/A
Revenue
★ $646,804,000.00
$193,015,000.00
Revenue This Year
$23.64
$3.94
Revenue Next Year
$19.79
$6.59
P/E Ratio
$63.47
★ N/A
Revenue Growth
★ 24.68
17.67
52 Week Low
$40.74
$3.31
52 Week High
$114.95
$6.21

Technical Indicators

Market Signals
Indicator
LMB
CTKB
Relative Strength Index (RSI) 40.62 51.62
Support Level $40.74 $4.17
Resistance Level $52.34 $6.21
Average True Range (ATR) 1.87 0.30
MACD -0.26 -0.04
Stochastic Oscillator 2.68 30.04

Price Performance

Historical Comparison
LMB
CTKB

About LMB Limbach Holdings Inc.

Limbach Holdings Inc is a building systems solutions firm that designs, delivers, and maintains mechanical (heating, ventilation, and air conditioning), electrical, plumbing, and controls (MEPC) systems. The Company partners with owners and operators of facilities across healthcare, industrial and manufacturing, data centers, life sciences, higher education, and cultural and entertainment markets. It operates through two segments: Owner Direct Relationships (ODR), which generates maximum revenue and includes owner direct projects, maintenance, and service on MEPC systems; and General Contractor Relationships (GCR), which manages new construction or renovation projects involving MEPC systems awarded by general contractors or construction managers.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

Share on Social Networks: